Navigation Links
Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
Date:5/7/2014

Shuganjieyu capsule has been approved for clinical treatment by the State Food and Drug Administration of China since 2008. In the clinic, Shuganjieyu capsule is often used to treat mild to moderate depression. Prof. Jingping Zhao and team from the Second Xiangya Hospital, Central South University in China conducted a study to examine the effect of Shuganjieyu capsule on behavioral changes in a rat model of depression. They focused on the underlying mechanisms of Shuganjieyu capsule by examining brain-derived neurotrophic factor and phosphorylated cyclic adenosine monophosphate response element binding protein expression levels in the medial prefrontal cortex and hippocampal CA3 area. The results presented in this study demonstrate that Shuganjieyu capsule effectively reverses depressive-like behaviors by increasing brain-derived neurotrophic factor and phosphorylated cyclic adenosine monophosphate response element binding protein expression levels in the medial prefrontal cortex and hippocampalCA3 area of depressive-like rats, which may be one of the anti-depressant mechanisms of Shuganjieyu capsule. This study has been published in the Neural Regeneration Research (Vol. 9, No. 5, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related medicine news :

1. Vibrating capsule shows promising results in treating chronic constipation
2. Turmeric Curcumin Capsules by Everpure are Now Discounted on Amazon
3. LidaSale.com Launches A Big Promotion Of Its Popular Product Daidaihua Capsules
4. Diet Doc Weight Loss Plans Announces New Enteric-Coated 700 mg Pure Fish Oil Capsules, Shown to Strengthen Brain Cells
5. Diet Doc Medical Weight Loss Plans Offers New Pure Fish Oil Capsules That Provide Countless Health Benefits
6. Demand for Li Da Daidaihua Weight Loss Capsules From NLslimming.com Increases Rapidly in the US Market
7. Rancid Fish Oil Capsules May Partly Explain Omega-3 and Prostate Cancer Findings, Suggest Co-founders of Omega3 Innovations
8. Omega3 Innovations Launches a New Omega Passion Chocolate Truffle to Replace Regular Fish Oil Capsules
9. Tiny capsule effectively kills cancer cells
10. Capsule Endoscopy (Smart/Digital Pills) Market is expected to grow at a CAGR of 17% & to reach $965 Million by 2017 - by MarketsandMarkets
11. Evidence that new biomimetic controlled-release capsules may help in gum disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: